Replimune Group (REPL) Stock Research

Today

Replimune 9.7M share Spot Secondary priced at $12.06

REPL

8:28 AM

Friday

Replimune price target raised by $4 at BMO Capital, here's why

REPL

Aug 7, 7:55 AM

Wedbush upgrades Replimune to Outperform following FDA decision

REPL

Aug 7, 6:26 AM

Wedbush gets more bullish on Replimune, upgrades shares

REPL

Aug 7, 6:20 AM

Thursday

Replimune announces FDA accelerated approval of Tudriqev for advanced melanoma

REPL

Aug 6, 5:46 PM

Tuesday

Walmart downgraded, Palantir upgraded: Wall Street's top analyst calls

+14

Aug 4, 9:37 AM

Replimune just upgraded at Leerink, here's why

REPL

Aug 4, 5:02 AM

Over a week ago

What You Missed On Wall Street On Friday

+30

Jul 31, 4:13 PM

Midday Fly By: Apple sinks after guidance, Amazon's AWS powers beat

+26

Jul 31, 12:10 PM

Roblox downgraded, Quanta Services upgraded: Wall Street's top analyst calls

+13

Jul 31, 9:46 AM

Morning Movers: Amazon jumps after quarterly results while Apple slips

+10

Jul 31, 8:52 AM

Piper upgrades Replimune to Overweight on better odds of RP1 approval

REPL

Jul 31, 8:48 AM

Piper Sandler gets more bullish on Replimune, upgrades shares

REPL

Jul 31, 8:44 AM

Replimune price target raised by $3 at Wedbush, here's why

REPL

Jul 31, 8:24 AM

Replimune just upgraded at Cantor Fitzgerald, here's why

REPL

Jul 31, 4:50 AM

Replimune confirms FDA AdCom voted in favor of experimental melanoma treatment

REPL

Jul 30, 6:17 PM

FDA panel votes 10-3 in favor of Replimune's experimental melanoma treatment

REPL

Jul 30, 5:42 PM

Wedbush sees key AdCom vote favoring Replimune on efficacy signal

REPL

Jul 28, 11:21 AM

BMO sees 'uphill battle' for Replimune at Thursday's FDA panel meeting

REPL

Jul 28, 10:56 AM

Replimune sinks after FDA briefing documents question RP1 data

REPL

Jul 28, 10:51 AM

Unusually active option classes on open July 28th

Jul 28, 9:40 AM

Replimune Group put volume heavy and directionally bearish

REPL

Jul 27, 10:55 AM

Capricor briefing documents paint 'ugly picture,' says Cantor Fitzgerald

Jul 27, 10:17 AM

Replimune Group put volume heavy and directionally bearish

REPL

Jul 20, 11:15 AM

Replimune Group put volume heavy and directionally bearish

REPL

Jul 8, 12:35 PM

Today

Replimune 9.7M share Spot Secondary priced at $12.06

REPL

8:28 AM

Friday

Replimune price target raised by $4 at BMO Capital, here's why

REPL

Aug 7, 7:55 AM

Wedbush upgrades Replimune to Outperform following FDA decision

REPL

Aug 7, 6:26 AM

Wedbush gets more bullish on Replimune, upgrades shares

REPL

Aug 7, 6:20 AM

Thursday

Replimune announces FDA accelerated approval of Tudriqev for advanced melanoma

REPL

Aug 6, 5:46 PM

Tuesday

Walmart downgraded, Palantir upgraded: Wall Street's top analyst calls

+14

Aug 4, 9:37 AM

Replimune just upgraded at Leerink, here's why

REPL

Aug 4, 5:02 AM

Over a week ago

What You Missed On Wall Street On Friday

+30

Jul 31, 4:13 PM

Midday Fly By: Apple sinks after guidance, Amazon's AWS powers beat

+26

Jul 31, 12:10 PM

Roblox downgraded, Quanta Services upgraded: Wall Street's top analyst calls

+13

Jul 31, 9:46 AM

Morning Movers: Amazon jumps after quarterly results while Apple slips

+10

Jul 31, 8:52 AM

Piper upgrades Replimune to Overweight on better odds of RP1 approval

REPL

Jul 31, 8:48 AM

Piper Sandler gets more bullish on Replimune, upgrades shares

REPL

Jul 31, 8:44 AM

Replimune price target raised by $3 at Wedbush, here's why

REPL

Jul 31, 8:24 AM

Replimune just upgraded at Cantor Fitzgerald, here's why

REPL

Jul 31, 4:50 AM

Replimune confirms FDA AdCom voted in favor of experimental melanoma treatment

REPL

Jul 30, 6:17 PM

FDA panel votes 10-3 in favor of Replimune's experimental melanoma treatment

REPL

Jul 30, 5:42 PM

Wedbush sees key AdCom vote favoring Replimune on efficacy signal

REPL

Jul 28, 11:21 AM

BMO sees 'uphill battle' for Replimune at Thursday's FDA panel meeting

REPL

Jul 28, 10:56 AM

Replimune sinks after FDA briefing documents question RP1 data

REPL

Jul 28, 10:51 AM

Unusually active option classes on open July 28th

Jul 28, 9:40 AM

Replimune Group put volume heavy and directionally bearish

REPL

Jul 27, 10:55 AM

Capricor briefing documents paint 'ugly picture,' says Cantor Fitzgerald

Jul 27, 10:17 AM

Replimune Group put volume heavy and directionally bearish

REPL

Jul 20, 11:15 AM

Replimune Group put volume heavy and directionally bearish

REPL

Jul 8, 12:35 PM

Company News

Charts